A detailed history of Hancock Whitney Corp transactions in Zynex Inc stock. As of the latest transaction made, Hancock Whitney Corp holds 28,444 shares of ZYXI stock, worth $222,147. This represents 0.01% of its overall portfolio holdings.

Number of Shares
28,444
Previous 28,637 0.67%
Holding current value
$222,147
Previous $266,000 12.78%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$7.19 - $10.31 $1,387 - $1,989
-193 Reduced 0.67%
28,444 $232,000
Q2 2024

Aug 13, 2024

SELL
$8.63 - $12.56 $36,815 - $53,580
-4,266 Reduced 12.97%
28,637 $266,000
Q1 2024

May 16, 2024

BUY
$9.86 - $13.74 $64,740 - $90,216
6,566 Added 24.93%
32,903 $407,000
Q4 2023

Feb 14, 2024

SELL
$7.1 - $10.89 $39,248 - $60,199
-5,528 Reduced 17.35%
26,337 $286,000
Q3 2023

Nov 13, 2023

BUY
$6.95 - $9.89 $5,295 - $7,536
762 Added 2.45%
31,865 $254,000
Q2 2023

Nov 13, 2023

BUY
$8.59 - $14.56 $131,839 - $223,466
15,348 Added 97.42%
31,103 $298,000
Q2 2023

Aug 10, 2023

BUY
$8.59 - $14.56 $131,839 - $223,466
15,348 Added 97.42%
31,103 $298,000
Q1 2023

Nov 13, 2023

SELL
$9.53 - $16.8 $2,801 - $4,939
-294 Reduced 1.83%
15,755 $189,000
Q1 2023

May 16, 2023

SELL
$9.53 - $16.8 $2,801 - $4,939
-294 Reduced 1.83%
15,755 $188,000
Q4 2022

Nov 13, 2023

SELL
$8.71 - $14.28 $131,120 - $214,971
-15,054 Reduced 48.4%
16,049 $223,000
Q4 2022

Feb 03, 2023

BUY
$8.71 - $14.28 $139,786 - $229,179
16,049 New
16,049 $223,000
Q2 2020

Jul 30, 2020

SELL
$9.06 - $23.49 $136,461 - $353,806
-15,062 Closed
0 $0
Q1 2020

May 08, 2020

SELL
$7.2 - $13.09 $9,223 - $16,768
-1,281 Reduced 7.84%
15,062 $167,000
Q3 2019

Oct 29, 2019

BUY
$6.69 - $9.65 $109,334 - $157,709
16,343 New
16,343 $155,000

Others Institutions Holding ZYXI

About ZYNEX INC


  • Ticker ZYXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 37,453,400
  • Market Cap $293M
  • Description
  • Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...
More about ZYXI
Track This Portfolio

Track Hancock Whitney Corp Portfolio

Follow Hancock Whitney Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.